Last reviewed · How we verify
NCT04305132
Effect of Electroconvulsive Therapy on Retinal Nerve Fiber Layer Thickness in Depression
trial testing Electroconvulsive therapy in Depression in 50 participants. Status unknown.
30 June 2021
Quick facts
| Lead sponsor | Mehmet Diyaddin Güleken |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 January 2020 |
| Primary completion | 30 June 2021 |
| Estimated completion | 30 September 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Electroconvulsive therapy
Conditions studied
- Depression — all drugs for Depression →
Sponsor
Mehmet Diyaddin Güleken
Who can join
Adults 18 to 65, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the changes in the retinal nerve fiber layer thickness of the patients with depression who received electroconvulsive therapy by means of optical coherence tomography.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04305132
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Electroconvulsive therapy
Trials testing the same drug.
- NCT07324070 — Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression · NA · recruiting
- NCT06355180 — Esketamine vs ECT for Acute Suicidality · NA · completed
- NCT05973643 — Metabolomics During ElectroConvulsivoTherapy · NA · recruiting
- NCT05630469 — Prediction of Antidepressant Effects of Electroconvulsive Therapy · recruiting
- NCT05465915 — Pulse Width 0.15ms vs 0.30ms in Electroconvulsive Therapy · EARLY_PHASE1 · unknown
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Other Mehmet Diyaddin Güleken trials
Trials by the same sponsor.
- NCT04717921 — Assesment of Retinal Nerve Fiber Layer in First Episode Depressive Patients Using Selective Serotonin Reuptake Inhibitor · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04305132 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mehmet Diyaddin Güleken
- Last refreshed: 27 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04305132.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing